Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001019056-16-001455
Filing Date
2016-08-05
Accepted
2016-08-05 19:43:38
Documents
1
Period of Report
2016-08-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT elhibri_4.html 4  
1 OWNERSHIP DOCUMENT elhibri_4.xml 4 7150
  Complete submission text file 0001019056-16-001455.txt   8501
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address
El-Hibri Fuad (Reporting) CIK: 0001380185 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37746 | Film No.: 161812326

Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Issuer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations